| Company Name: | Laboratory Corporation of America Holdings | | Ticker Symbol: | LH | | | WWW Address: | www.labcorp.com | | CEO: | David P. King | | No. of Employees: | 28,000 | | Common Issue Type: | CS | | Business Description: | Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis and in the monitoring and treatment of disease.
|
| | | Industry Information: | HEALTH SERVICES - Medical Laboratories & Research [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 74.47 |  -0.13 | 74.46 | 74.49 | 74.52 | 74.80 | 74.04 | 104447 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 7,908.7 | 106.2 | 0.50 | 4.16 | 0.00 | 15.6 | 0.0 | 74.80 - 53.25 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 74.60 | $ | | PE Ratio - LTM | 15.6 | |
| Market Capitalisation | 7,922.5 | mil |
| Latest Shares Outstanding | 106.2 | mil |
| Earnings pS (EPS) | 4.16 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 160,900 | $ |
| Effective Tax Rate | 39.2 | % |
| Float | 107.9 | mil |
| Float as % of Shares Outstanding | 99.6 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 20.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 44.6 | % |
| EBITDA Margin | 24.3 | % |
| Pre-Tax Profit Margin | 18.9 | % |
| Assets Turnover | 1.0 | % |
| Return on Assets (ROA) | 10.9 | % |
| Return on Equity (ROE) | 25.9 | % |
| Return on Capital Invested (ROCI) | 15.9 | % |
| Current Ratio | 1.6 | |
| Leverage Ratio (Assets/Equity) | 2.4 | |
| Interest Cover | 14.1 | |
| Total Debt/Equity (Gearing Ratio) | 0.69 | |
| LT Debt/Total Capital | 39.0 | % |
| Working Capital pS | 3.53 | $ |
| Cash pS | 1.19 | $ |
| Book-Value pS | 19.10 | $ |
| Tangible Book-Value pS | -11.00 | $ |
| Cash Flow pS | 6.74 | $ |
| Free Cash Flow pS | 5.05 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 3.91 | |
| Price/Tangible Book Ratio | -6.78 | |
| Price/Cash Flow | 11.1 | |
| Price/Free Cash Flow | 14.8 | |
| P/E as % of Industry Group | 53.0 | % |
| P/E as % of Sector Segment | 83.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.3 | 100 | 5,657 | 8,397 |
| 4 Weeks | 74.80 | 68.97 | 68.89 | 8.3 | 101 | 7,002 | 119,042 |
| 13 Weeks | 74.80 | 62.06 | 70.46 | 5.9 | 98 | 13,572 | 827,894 |
| 26 Weeks | 74.80 | 59.76 | 60.96 | 22.4 | 102 | 13,315 | 1,664,352 |
| 52 Weeks | 74.80 | 53.25 | 63.36 | 17.7 | 95 | 13,317 | 3,315,936 |
| YTD | 74.80 | 53.25 | - | 15.8 | 95 | 13,472 | 3,058,211 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 74.03 | 73.69 | 69.44 | 67.13 | 64.93 | 0.50 | 0.48 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 8.93 | 97.4 | 8.89 |
| Income | 13.97 | 96.5 | 12.39 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.43 | NA | 13.93 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 14.32 | NA | 11.21 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 4.2 | 4.4 | 10.7 |
| Earnings % | 15.6 | 17.4 | -2.6 |
| EPS % | 19.9 | 21.0 | 5.9 |
| EPS $ | 0.61 | 0.21 | 0.23 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 10.41 |
| Current Ratio | 1.9 |
| Quick Ratio (Acid Test) | 1.6 |
| Liquidity Ratio (Cash) | 0.40 |
| Receivables Turnover | 7.2 |
| Average Collection Period | 50 |
| Working Capital/Equity | 28.8 |
| Working Capital pS | 4.49 |
| Cash-Flow pS | 5.95 |
| Free Cash-Flow pS | 2.41 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.47 |
| Financial Leverage Ratio (Assets/Equity) | 2.8 |
| Debt Ratio | 63.8 |
| Total Debt/Equity (Gearing Ratio) | 1.02 |
| LT Debt/Equity | 0.95 |
| LT Debt/Capital Invested | 74.0 |
| LT Debt/Total Liabilities | 53.7 |
| Interest Cover | 11.7 |
| Interest/Capital Invested | 1.75 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 75.89 |
| Tobin's Q Ratio | 1.70 |
| Current P/E Ratio - LTM | 15.60 |
| Enterprise Value (EV)/EBITDA | 10.07 |
| Enterprise Value (EV)/Free Cash Flow | 46.86 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -6.78 |
| Price/Book Ratio - LTM | 3.91 |
| Price/Cash Flow Ratio | 11.1 |
| Price/Free Cash Flow Ratio - LTM | 14.8 |
| Price/Sales Ratio | 1.70 |
| P/E Ratio (1 month ago) - LTM | 14.8 |
| P/E Ratio (26 weeks ago) - LTM | 14.4 |
| P/E Ratio (52 weeks ago) - LTM | 15.7 |
| 5-Y High P/E Ratio | 22.9 |
| 5-Y Low P/E Ratio | 12.7 |
| 5-Y Average P/E Ratio | 19.5 |
| Current P/E Ratio as % of 5-Y Average P/E | 80 |
| P/E as % of Industry Group | 53.0 |
| P/E as % of Sector Segment | 83.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 15.2 |
| PER SHARE FIGURES |
| LT Debt pS | 14.78 |
| Current Liabilities pS | 5.05 |
| Tangible Book Value pS - LTM | -11.00 |
| Book Value pS - LTM | 19.10 |
| Capital Invested pS | 30.97 |
| Cash pS - LTM | 1.19 |
| Cash Flow pS - LTM | 6.74 |
| Free Cash Flow pS - LTM | 5.05 |
| Earnings pS (EPS) | 4.16 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 5.78 |
| Free Cash Flow Margin 5YEAR AVG | 8.93 |
| Net Profit Margin | 10.3 |
| Net Profit Margin - 5YEAR AVRG. | 11.4 |
| Equity Productivity | 2.67 |
| Return on Equity (ROE) | 27.5 |
| Return on Equity (ROE) - 5YEAR AVRG. | 22.9 |
| Capital Invested Productivity | 1.37 |
| Return on Capital Invested (ROCI) | 14.1 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 15.1 |
| Assets Productivity | 1.00 |
| Return on Assets (ROA) | 9.9 |
| Return on Assets (ROA) - 5YEAR AVRG. | 10.3 |
| Gross Profit Margin | 44.6 |
| Gross Profit Margin - 5YEAR AVRG. | 44.7 |
| EBITDA Margin - LTM | 24.3 |
| EBIT Margin - LTM | 20.3 |
| Pre-Tax Profit Margin | 17.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 19.2 |
| Effective Tax Rate | 39.2 |
| Effective Tax Rate - 5YEAR AVRG. | 40.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 62 |
| Revenue per Employee | 160,900 |
| Net Income per Employee | 16,589 |
| Average Collection Period | 50 |
| Receivables Turnover | 7.2 |
| Day's Inventory Turnover Ratio | 12 |
| Inventory Turnover | 29.3 |
| Inventory/Sales | 2.0 |
| Accounts Payble/Sales | 3.54 |
| Assets/Revenue | 1.00 |
| Net Working Capital Turnover | 9.27 |
| Fixed Assets Turnover | 1.24 |
| Total Assets Turnover | 1.0 |
| Revenue per $ Cash | 20.51 |
| Revenue per $ Plant | 9.08 |
| Revenue per $ Common Equity | 2.67 |
| Revenue per $ Capital Invested | 1.37 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 20.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 20.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |